Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
40.80
-0.82 (-1.97%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
3 Bill Gates Stocks to Buy for Billionaire-Like Returns
October 27, 2023
Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.
Via
InvestorPlace
3 Deeply Undervalued Growth Stocks
October 27, 2023
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks.
Via
InvestorPlace
Peering Into GSK's Recent Short Interest
October 26, 2023
Via
Benzinga
Price Over Earnings Overview: GSK
October 24, 2023
Via
Benzinga
Bank Of America, Mastercard, NRA And Others Are Lobbying For Cannabis Banking Reform — Who Knew?
October 22, 2023
Several entities have included the Secure and Fair Enforcement Regulation (SAFER) Banking Act on their lobbying disclosures for the third quarter of 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...
Via
Talk Markets
(GSK) - Analyzing GSK's Short Interest
October 09, 2023
Via
Benzinga
Price Over Earnings Overview: GSK
September 22, 2023
Via
Benzinga
GSK: Pharma Giant Prioritizing Shareholder Dividends
October 13, 2023
A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright.
Via
Talk Markets
Google AI-Powered Chatbot's Ethical Concerns, MGM Hackers Waited For Days Before Issuing Financial Demands, Costco Accused Of Sharing Confidential Health Data With Facebook: Today's Top Stories
October 11, 2023
Bloomberg Google's AI Dilemma - Bard's Promise Versus Ethical Concerns
Via
Benzinga
Topics
Artificial Intelligence
Hacking
Exposures
Artificial Intelligence
Information Security
Little Less Heartburn For GSK: Settles Another California Lawsuit On Zantac
October 11, 2023
GSK plc (NYSE: GSK) has reached a confidential settlement in the Cantlay/Harper case filed in California state court.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
China-Based Zhifei Biological Partners With GSK To Expand Shingrix Vaccine Access Across China Via £2.5B Deal
October 09, 2023
GSK plc (NYSE: GSK) has reached an exclus
Via
Benzinga
How Is The Market Feeling About GSK?
September 19, 2023
Via
Benzinga
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
October 06, 2023
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger
Via
Benzinga
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
October 06, 2023
GSK Plc (NYSE: GSK) said it raised £885.6 million (
Via
Benzinga
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
October 03, 2023
AstraZeneca Plc (NASDAQ: AZN) has
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Read the latest report on NanoViricides here
Via
Benzinga
7 ‘Smart Money’ Stocks Set to Explode Higher
September 30, 2023
Invest like the pros by wagering on these top seven smart money stocks to buy at this time, offering tremendous upside ahead.
Via
InvestorPlace
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
Moderna stock soared early in the pandemic.
Via
The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...
Via
Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
Read the latest report on NanoViricides here
Via
Benzinga
Why Are Antifungal Focused Scynexis Stock Plunging Today?
September 25, 2023
Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga
Via
Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe RSV
Via
Benzinga
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Bloomberg
Via
Benzinga
European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug
September 19, 2023
The European Commission has approved ViiV Healthcare's Apretude (cabotegravir long-acting (LA) injectable and tablets)
Via
Benzinga
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Friday, the FDA approved GSK plc's (NYSE: GSK) Ojjaara (momelotinib) for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and...
Via
Benzinga
Exposures
Product Safety
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
September 18, 2023
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer.
Via
Investor's Business Daily
One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
September 18, 2023
Treatment-resistant depression, also referred to as TRD, is a subset of depression that poses significant challenges for clinicians, patients and those closest to patients. It is characterized by...
Via
Benzinga
Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal
September 18, 2023
FDA has
Via
Benzinga
Exposures
Product Safety
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.